GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3401 - 3425** of **4050** in total

« First

‹ Prev

…

133

134

135

136

137

138

139

140

141

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgA	Patient 2	3	mild	G26125KY	634
IgA	Patient 4	12	mild	G17266GE	634
IgA	Patient 1	22	moderate	G71469XA	635
IgA	Patient 4	12	mild	G58969RU	635
IgA	Patient 2	15	mild	G17689EW	636
IgM	Patient 1	22	moderate	G17140UR	637
IgM	Patient 2	3	mild	G25559RS	639
IgA	Patient 3	11	mild	G35446HX	639
IgA	Patient 2	3	mild	G82779CI	642
IgA	Patient 3	11	mild	G49916XD	642
IgA	Patient 4	12	mild	G98068PA	645
IgG	Patient 4	12	mild	G99603GB	646
IgA	Patient 2	15	mild	G78255UI	647
IgM	Patient 1	22	moderate	G47362BJ	651
IgG	Patient 3	11	mild	G43648DB	652
IgM	Patient 4	12	mild	G86566MF	652
IgA	Patient 2	3	mild	G29011JC	655
IgA	Patient 4	12	mild	G90562PB	656
IgA	Patient 4	12	mild	G53168IY	660
IgA	Patient 4	12	mild	G16579HJ	663
IgA	Patient 2	15	mild	G69912LP	664
IgA	Patient 2	24	mild	G90223GH	664
IgA	Patient 2	24	mild	G39213VZ	665
IgA	Patient 2	24	mild	G51175PR	665
IgM	Patient 2	15	mild	G36544AC	665